Hydromorphone 2mg modified-release capsules
BNF presentation 040702050AAAFAF within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040702050AAAFAF
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
248
NHS spend (£)
£3,818.74
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 24 |
| December 2024 | 3 |
| November 2024 | 27 |
| October 2024 | 37 |
| August 2024 | 5 |
| July 2024 | 34 |
| May 2024 | 13 |
| July 2021 | 16 |
| June 2021 | 6 |
| December 2020 | 52 |
| November 2020 | 31 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 18 | No data available |
| Unknown pharmacy | 16 | No data available |
|
Alnwick Medical Group
ODS A84006
|
15 | 00L - NORTH EAST AND NORTH CUMBRIA ICB |
| Unknown pharmacy | 15 | No data available |
| Unknown pharmacy | 13 | No data available |
| Unknown pharmacy | 11 | No data available |
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 5 | No data available |